1,25-Dihydroxyvitamin D3 receptors and human colon adenocarcinoma
β Scribed by Professor P. Lointier; F. Meggouh; P. Dechelotte; D. Pezet; C. H. Ferrier; J. Chipponi; S. Saez
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 480 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In this communication we describe the synthesis of \(1 \alpha, 25\)-dihydroxyvitamin \(\mathrm{D}_{3}\) - \(3 \beta\)-bromoacetate \(\left[1,25(\mathrm{OH})_{2}-\mathrm{BE}\right]\), an analog of \(1 \alpha, 25\)-dihydroxyvitamin \(\mathrm{D}_{3}\left[1,25(\mathrm{OH})_{2} \mathrm{D}_{3}\right]\), a
## Abstract Treatment with 10^β8^ m 1,25βdihydroxyvitamin D~3~ for 24 h causes transcriptional activation of the human insulin receptor gene in Uβ937 human promonocytic cells. The activation seems to potentiate the response to insulin in terms of glucose oxidation. Wortmannin, a phosphatidylinosito
A number of recent clinical observations suggest that vitamin D 3 plays an important role in maintaining normal cardiovascular function, either directly through its receptor in cardiac muscle, or indirectly through its infuence on circulating levels of calcium or on other regulatory factors. By usin